Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 0.07 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 0.18 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 0.2 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 0.11 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 0.26 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 0.32 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 0.29 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 0.28 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 0.0 | BCD100427B001 | 0.28 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 0.5 | BCD100427B003 | 0.33 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 1.0 | BCD100427B007 | 0.35 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 2.0 | BCD100427B011 | 0.43 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 4.0 | BCD100427B015 | 0.28 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 8.0 | BCD100427B019 | 0.42 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 12.0 | BCD100427B023 | 0.28 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 24.0 | BCD100427B027 | 0.4 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 0.17 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 0.19 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 0.15 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 0.23 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 0.4 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 0.25 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 0.2 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 0.5 | BCD100427B004 | 0.27 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 1.0 | BCD100427B008 | 0.3 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 2.0 | BCD100427B012 | 0.37 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 4.0 | BCD100427B016 | 0.47 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 8.0 | BCD100427B020 | 0.48 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 12.0 | BCD100427B024 | 0.43 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 24.0 | BCD100427B028 | 0.32 | pmol/sample |